The Impact of COVID-19 on the Pharma Industry and Recent Developments Involving Biosimilars and Generics 

Oct. 21, 2020
Online

CBA Competition Law Fall Online Symposium

The Impact of COVID-19 on the Pharma Industry and Recent Developments Involving Biosimilars and Generics

Presented by the CBA Competition Law Section

CBA members: $55
CBA Young Lawyer Members (<5 years): $40
CBA Student members: $10
Non-members: $220
Plus applicable taxes

Registrants will receive an on-demand recording following each webcast. All sessions will be presented in English.
This is the 5th webinar in the CBA Competition Law Fall Online Symposium. You can purchase the full program at a package rate.


WEDNESDAY, OCTOBER 21, 12:30 PM TO 1:45 PM ET

12:30 pm – 1:45 pm The Impact of COVID-19 on the Pharma Industry and Recent Developments Involving Biosimilars and Generics

Sponsored by
Bates White Economic Consulting

This panel will discuss how competition laws might impact the development and distribution of COVID-19 vaccines and medicines, and related competitor collaboration. Our experts will also explore novel issues raised by biosimilars, including in the context of class actions and the recently published joint statement from the FTC and the FDA, and access of branded samples to generic manufacturers following the Otsuka investigation.

Moderator:        
Davit Akman, Borden Ladner Gervais LLP

Speakers:           
Eric Grannon, White & Case LLP
Eric Lefebvre, Norton Rose Fulbright LLP
Krista McWhinnie, Deputy Commissioner, Monopolistic Practices Directorate, Competition Bureau
Markus Meier, Assistant Director, Bureau of Competition, Federal Trade Commission

The webinar will include a Q&A portion

 

printPrint     Bookmark and Share

    FORMAT
    Webinars

    SPONSORED BY

    Analysis Group

    Bates White Economic Group
     

    The Brattle Group
     

    Charles River Associates
     

    Competition Arbitration
     

    Epiq global
     

    KLDiscovery
     

    Longview Communications Inc.
     

     

     

     

 

CONTACT INFO

pd@cba.org
613-237-2925 | 1-800-267-8860
FAQ & Cancellation